PremiumCompany AnnouncementsRecordati Approves 2024 Financials and Appoints New Board FDA Approves Expanded Use of Recordati’s ISTURISA® for Cushing’s Syndrome Recordati Discloses Treasury Share Transactions and Buy-Back Program PremiumThe FlyRecordati upgraded to Hold from Sell at Deutsche Bank Recordati upgraded to Hold from Sell at Deutsche Bank Recordati Reports Strong 2024 Financial Results and Reaffirms ESG Commitment PremiumCompany AnnouncementsRecordati Updates Share Buyback Program Progress Rossini S.à r.l. Completes Secondary Share Placement in Recordati S.p.A. Rossini S.à r.l. Announces Sale of Recordati Shares